Canada markets close in 3 hours 41 minutes

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.13+0.41 (+1.80%)
As of 12:18PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.87B
Enterprise Value 853.72M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.64
Price/Book (mrq)1.91
Enterprise Value/Revenue 2.26
Enterprise Value/EBITDA -5.46

Trading Information

Stock Price History

Beta (5Y Monthly) 1.77
52-Week Change 3-32.46%
S&P500 52-Week Change 322.43%
52 Week High 349.50
52 Week Low 316.95
50-Day Moving Average 331.21
200-Day Moving Average 327.11

Share Statistics

Avg Vol (3 month) 31.52M
Avg Vol (10 day) 31.74M
Shares Outstanding 582.31M
Implied Shares Outstanding 682.31M
Float 873.36M
% Held by Insiders 11.84%
% Held by Institutions 187.07%
Shares Short (Apr 15, 2024) 413.17M
Short Ratio (Apr 15, 2024) 410.27
Short % of Float (Apr 15, 2024) 420.97%
Short % of Shares Outstanding (Apr 15, 2024) 416.00%
Shares Short (prior month Mar 15, 2024) 414.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -35.09%
Operating Margin (ttm)42.02%

Management Effectiveness

Return on Assets (ttm)-7.87%
Return on Equity (ttm)-15.46%

Income Statement

Revenue (ttm)377.71M
Revenue Per Share (ttm)4.90
Quarterly Revenue Growth (yoy)1,478.00%
Gross Profit (ttm)N/A
EBITDA -156.47M
Net Income Avi to Common (ttm)-132.53M
Diluted EPS (ttm)-1.72
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.19B
Total Cash Per Share (mrq)15.11
Total Debt (mrq)173.17M
Total Debt/Equity (mrq)17.65%
Current Ratio (mrq)5.89
Book Value Per Share (mrq)12.47

Cash Flow Statement

Operating Cash Flow (ttm)-149.2M
Levered Free Cash Flow (ttm)-50.84M